The CHMP has specifically backed Leqembi to treat mild cognitive impairment or mild dementia from Alzheimer’s but only for patients carrying one or no copy of the ApoE4 gene.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback